Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke

Timothy J Bernard1, Laura Z Fenton, Susan D Apkon

  • 1Department of Pediatrics, Section of Child Neurology, Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado Denver and The Children's Hospital, Aurora, CO 80045-0507, USA. timothy.bernard@ucdenver.edu

The Journal of Pediatrics
|December 22, 2009
PubMed

Insights

Biomarkers like D-dimer and C-reactive protein (CRP) are often elevated in children with arterial ischemic stroke (AIS). Elevated D-dimer levels may indicate a cardioembolic cause in pediatric AIS.

Area of Science:

  • Pediatric Neurology
  • Vascular Neurology
  • Biomarker Discovery

Background:

  • Arterial ischemic stroke (AIS) in children is a significant cause of long-term disability.
  • Understanding the underlying pathophysiology and identifying risk factors for recurrence are crucial in pediatric AIS.
  • Hypercoagulability and inflammation are suspected contributors to AIS in children.

Purpose of the Study:

  • To investigate the prevalence of hypercoagulability and inflammation biomarkers in acute childhood-onset AIS.
  • To determine if these biomarkers differ among specific etiologic subtypes of pediatric AIS.
  • To assess the utility of D-dimer in identifying cardioembolic AIS in children.

Main Methods:

  • Prospective/retrospective cohort study of 50 children with acute AIS (2005-2009).
  • Serial evaluation of D-dimer, factor VIII (FVIII) activity, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR).
  • Classification of patients by stroke subtype: cardioembolic, moyamoya, non-moyamoya arteriopathy, or other.

Main Results:

  • D-dimer and CRP were frequently elevated in acute childhood AIS, decreasing over time.
  • Acute D-dimer levels were significantly higher in cardioembolic AIS compared to noncardioembolic AIS (P = .002).
  • D-dimer > or = 0.50 microg/mL showed 78% sensitivity and 79% specificity for cardioembolic AIS.

Conclusions:

  • D-dimer and CRP are potential biomarkers for determining the cause and predicting the outcome of childhood AIS.
  • Further research is warranted to explore the role of these and other biomarkers in pediatric AIS.
  • These findings contribute to understanding the inflammatory and hypercoagulable states associated with pediatric stroke.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...